Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1999, p. 633-637, Vol. 37, No. 3
Department of
Pediatrics1 and
Department of Clinical
Microbiology,
Received 13 May 1998/Returned for modification 22 October
1998/Accepted 18 November 1998
Blood-based pneumolysin PCR was compared to blood culture and
detection of pneumolysin immune complexes, as well as to detection of antibodies to pneumolysin and to C polysaccharide, in the
diagnosis of pneumococcal infection in 75 febrile
children. Invasive pneumococcal infection was suspected on clinical
grounds in 67 of the febrile children, and viral infection was
suspected on clinical grounds in 8 of the febrile children. In
addition, 15 healthy persons were examined to test the specificity of
the PCR assay. Plasma, serum, and leukocyte fractions were analyzed by
PCR. The combination of all test results led to the diagnosis of
pneumococcal infection in 25 patients. Pneumolysin PCR was positive in
44% of these children, an increase occurred in the pneumolysin
antibodies in 39% and in the C polysaccharide antibodies in 30% of
the patients; pneumolysin immune complexes were found in
convalescent serum in 30%, pneumolysin immune complexes occurred
in acute-phase serum samples in 16%, and a positive blood culture was
found in 20% of the patients. None of the healthy controls had
positive results by PCR. The results suggest that the diagnosis of
Streptococcus pneumoniae infection from blood samples
necessitates the use of several different assays. Pneumolysin PCR was
the most sensitive assay, but its clinical value is reduced by the fact
that three blood fractions are needed.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Pneumolysin PCR-Based Diagnosis of Invasive
Pneumococcal Infection in Children

*
Corresponding author. Mailing address: Research Unit,
Department of Pediatrics, Turku University Hospital, Vähä
Hämeenkatu 1 A 3, FIN-20500 Turku, Finland. Phone:
358-2-261-2486. Fax: 358-2-261-1485. E-mail:
pia.toikka{at}utu.fi.
Present address: Stanford University School of Medicine, Dept. of
Microbiology and Immunology, PAVAHCS, Palo Alto, CA 94304.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|